16th Open Scientific EIP Symposium on Immunogenicity of Biopharmaceuticals
Lisbon, Portugal
Request a meeting with our team in Rome to learn how we help our clients advance their therapeutic drug programs.
Request a meeting with our team in Lisbon to learn how we help our clients advance their therapeutic drug programs.
BioAgilytix Presentations at EIP
.jpg?width=400&height=400&name=Christopher%20Tiedtje%20(2).jpg "Christopher Tiedtje from BioAgilytix")
Christopher Tiedje, PhD, Scientific Operations
Wednesday, February 26, 9:00
Daniel Worms, PhD, Scientific Operations
Wednesday, 26 February, 11:15
.jpeg?width=400&height=403&name=RobNelson_edit%20(2).jpeg "RobNelson_edit (2)")
Robert Nelson, PhD, Scientific Officer
Wednesday, February 26, 14:45
BioAgilytix Posters at EIP
Ivonne Bernal, PhD, Scientific Operations
BioAgilytix Presentations at EIP
Christopher Tiedje, PhD, Scientific Operations
Wednesday, February 26, 9:00
Daniel Worms, PhD, Scientific Operations
Wednesday, 26 February, 11:15
Robert Nelson, PhD, Scientific Officer
Wednesday, February 26, 14:45
BioAgilytix Posters at EIP
Ivonne Bernal, PhD., Scientific Operations
Schedule a meeting with our experts on site
Learn how the combination of world-class scientific expertise, outstanding project management, and key regulatory insight can streamline our support for your therapeutic.
Schedule a meeting with our experts on site
Learn how the combination of world-class scientific expertise, outstanding project management, and key regulatory insight can streamline our support for your therapeutic.
About the event
The European Immunogenicity Platform (EIP) acts as a central meeting place for European biopharmaceutical companies and scientific experts active in the area of immunogenicity. Its mission is to increase knowledge and expertise in the field of immunogenicity, fostered by close interactions between industry and scientific advisors. EIP represents companies, institutes and professionals involved in research, development, testing, validation, application, production or marketing of immunogenicity assessment tools, as well as those servicing the biotechnology community.
.jpg?width=2000&height=1333&name=iStock-1449602358%20(1).jpg "BioAgilytix at EIP Lisbon, Portugal")
Partner with BioAgilytix for your immunogenicity project
BioAgilytix’s scientists are experts in the assessment of humoral and cellular immune responses to biotherapeutic modalities. When you partner with BioAgilytix you are connected to:
- Regulated data to support immunogenicity risk assessment for all biotherapeutics
- Support for global trials with labs in the U.S., Europe, and Australia
- Over 10 years of experience in immunogenicity risk assessment
- Experience in supporting studies in various species, including rodents, humans, and non-human primates
BioAgilytix has proven experience assessing immunogenicity for therapeutic modalities, including:
- ADA and NAb testing for large molecules and ATMPs
- Assays for detection of cellular immunogenicity
- Measurements of cytokine production
- Reagent labeling and oversight of surrogate positive control antibody generation
- Statistical analysis to support cut point generation
Schedule a meeting with our experts on site
Learn how the combination of world-class scientific expertise, outstanding project management, and key regulatory insight can streamline our support for your therapeutic.
© Copyright 2024 BioAgilytix Labs. All rights reserved.
Schedule a meeting with our experts on site
Learn how the combination of world-class scientific expertise, outstanding project management, and key regulatory insight can streamline our support for your therapeutic.
© Copyright 2024 BioAgilytix Labs. All rights reserved.